FDA 483 - Tulsa Fertility Center, P.C. - July 16, 2025

An FDA inspection of Tulsa Fertility Center, P.C. in Tulsa, OK, revealed a significant deficiency related to donor screening procedures. The firm failed to establish and maintain proper procedures for screening HCT/P donors, specifically lacking a method for administering the donor history screening questionnaire. This issue impacts numerous anonymous and directed oocyte and semen donors screened by the facility.